| ESCALON MEDICAL CORP |
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 |
| Balance Sheet Date | | | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 |
| Operating Cash Flow | | | 15,760$ | 30,695$ | 300,941$ | 33,329$ | (339,871$) | 175,190$ | (322,128$) | (115,962$) | 354,927$ | 240,815$ | 39,785$ | (310,381$) | (452,800$) | (15,678$) | (188,061$) | (393,386$) | (1,081$) | 123,137$ | 175,570$ | 541,079$ | (497,850$) | 465,025$ | (142,836$) | 7,166$ | (101,332$) | (122,663$) | (260,526$) | 11,832$ | | 365,135$ | | | | (115,343$) | | | (215,960$) | (387,372$) | (465,509$) | (128,162$) | 306,784$ | (95,225$) | (126,158$) | (541,935$) | (397,135$) | (154,756$) | (213,965$) |
| Investing Cash Flow | | | | | | | (9,247$) | 9,248$ | (21,958$) | (18,328$) | 0$ | (6,687$) | 0$ | (7,155$) | | | | | 0$ | 0$ | | | (20,780$) | (2,910$) | (36,061$) | (9,390$) | (15,611$) | 0$ | 0$ | (6,506$) | | 0$ | 500,000$ | (14,706$) | | 0$ | 0$ | 0$ | | (4,902$) | (764$) | (61,464$) | | (9,142$) | (14,004$) | (8,273$) | (2,707$) | (1,004$) | (14,487$) |
| Financing Cash Flow | | | (6,921$) | (10,339$) | (10,021$) | (12,634$) | (6,524$) | (10,140$) | (10,272$) | (10,520$) | (9,520$) | (3,274$) | (1,402$) | (1,175$) | (1,799$) | (1,747$) | (1,722$) | (1,663$) | (940$) | (927$) | (908$) | (889$) | 649,129$ | (858$) | (842$) | (822$) | (807$) | | (781$) | 36,069$ | 426$ | (25,426$) | (35,000$) | 75,000$ | | 3,000$ | | 0$ | | | | | | | | | | 0$ | |
| End Cash Position | | | 545,835$ | 797,426$ | 777,070$ | 486,150$ | 209,033$ | 564,707$ | 390,441$ | 744,831$ | 889,674$ | 544,320$ | 313,498$ | 275,147$ | 593,869$ | 1,048,500$ | 1,065,956$ | 1,255,824$ | 1,650,970$ | 1,653,087$ | 1,531,033$ | 1,365,954$ | 825,958$ | 695,648$ | 234,927$ | 415,818$ | 409,743$ | 528,280$ | 652,518$ | 415,818$ | 409,743$ | 1,127,920$ | 788,211$ | 429,885$ | 544,118$ | 425,941$ | 538,284$ | 372,533$ | 538,114$ | 618,588$ | 372,533$ | 1,327,135$ | 1,516,761$ | 1,214,817$ | 1,319,184$ | 1,459,346$ | 2,009,554$ | 2,409,396$ | 2,409,396$ |
| Exchange Rate Effect | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Dividends Paid | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |